共 50 条
- [1] Global Phase III Trials of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures[J]. NEUROLOGY, 2011, 76 (09) : A376 - A376French, JacquelineElger, ChristianGoldberg-Stern, HadassaThomson, AlfredoKrauss, Gregory L.Squillacote, DavidYang, HaichenKumar, Dinesh
- [2] Perampanel, an AMPA Receptor Antagonist, as Adjunctive Once-Daily Therapy in Patients with Refractory Partial-Onset Seizures: Safety and Tolerability Analysis from a Multicenter, Randomized Phase III Trial[J]. NEUROLOGY, 2011, 76 (09) : A291 - A292Krauss, Gregory L.Serratosa, Jose M.Villanueva, Vicente E.Endziniene, MildaHong, ZhenFrench, JacquelineYang, HaichenSquillacote, DavidZhu, JinLaurenza, Antonio
- [3] Global Phase III Trial of Perampanel, a Selective, Non-competitive AMPA Receptor Antagonist, as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures[J]. NEUROLOGY, 2011, 77 (02) : 199 - 200French, JacquelineElger, ChristianGoldberg-Stern, HadassaThomson, AlfredoKrauss, GregorySquillacote, DavidYang, Hai-chenKumar, DineshLaurenza, Antonio
- [4] USE OF PERAMPANEL, A SELECTIVE, NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES: RESULTS OF A GLOBAL PHASE III STUDY[J]. EPILEPSIA, 2011, 52 : 10 - 10French, J.Elger, C.Goldberg-Stern, H.Thomson, A.Krauss, G. L.Labiner, D.Squillacote, D.Yang, H.Kumar, D.Laurenza, A.
- [5] Determination of Tolerability, Safety, and Efficacy of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Subjects with Refractory Partial Seizures[J]. NEUROLOGY, 2009, 72 (11) : A442 - A442Krauss, Gregory L.Biton, VictorKlapper, Jack A.Bar, MichaelRektor, IvanVaiciene-Magistris, NerijaSkaringa, AlgimantasLiigant, AiveKumar, DineshSquillacote, David
- [6] DETERMINATION OF TOLERABILITY, SAFETY, AND EFFICACY OF PERAMPANEL, A SELECTIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN SUBJECTS WITH REFRACTORY PARTIAL SEIZURES[J]. EPILEPSIA, 2009, 50 : 103 - 103Krauss, G.Biton, V.Klapper, J.Bar, M.Rektor, I.Vaiciene-Magistris, N.Liigant, A.Kumar, D.Squillacote, D.
- [7] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF PERAMPANEL, A SELECTIVE, NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES: EFFICACY BY SEIZURE TYPE[J]. EPILEPSIA, 2011, 52 : 253 - 253Krauss, G.Wang, X-FHaldre, S.Yang, H.Squillacote, D.Zhu, J.Laurenza, A.
- [8] Perampanel, a Selective, Non-Competitive AMPA Receptor Antagonist as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures: A Dose Response Analysis from Phase III Studies[J]. NEUROLOGY, 2012, 78Kramer, LynnPerucca, EmilioBen-Menachem, ElinorKwan, PatrickShih, JerrySquillacote, DavidYang, HaichenZhu, JinLaurenza, Antonio
- [9] Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304[J]. NEUROLOGY, 2012, 79 (06) : 589 - 596French, Jacqueline A.Krauss, Gregory L.Biton, VictorSquillacote, DavidYang, HaichenLaurenza, AntonioKumar, DineshRogawski, Michael A.
- [10] PHASE III EVALUATION OF PERAMPANEL, A SELECTIVE, NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY FOR REFRACTORY PARTIAL-ONSET SEIZURES: EFFECTS ON SEIZURE FREEDOM AND OTHER EXPLORATORY EFFICACY END POINTS[J]. EPILEPSIA, 2011, 52 : 254 - 254Steinhoff, B. J.French, J.Kwan, P.Yang, H.Squillacote, D.Zhu, J.Laurenza, A.